Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HALAVEN for Breast cancer recurrent: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 24 adverse event reports in the FDA FAERS database where HALAVEN was used for Breast cancer recurrent.

Most Reported Side Effects for HALAVEN

Side Effect Reports % Deaths Hosp.
Neutropenia 11 14.3% 0 7
Febrile neutropenia 8 10.4% 1 7
Interstitial lung disease 8 10.4% 4 7
Anaemia 7 9.1% 0 5
Stomatitis 7 9.1% 2 4
Cardiac failure 6 7.8% 0 5
Malignant neoplasm progression 5 6.5% 1 3
Rectal haemorrhage 5 6.5% 0 4

Other Indications for HALAVEN

Breast cancer metastatic (18) Breast cancer (16) Product used for unknown indication (10)

Other Drugs Used for Breast cancer recurrent

ERIBULIN (346) PALBOCICLIB (318) ABEMACICLIB (298) EVEROLIMUS (180) LETROZOLE (163) TRASTUZUMAB (157) FULVESTRANT (155) PACLITAXEL (124) DOCETAXEL (111) PERTUZUMAB (95)

Related Pages

HALAVEN Full Profile All Breast cancer recurrent Drugs HALAVEN Demographics HALAVEN Timeline